BridgeBio Pharma, Inc. (BBIO) ownership: Top institutional holder: VANGUARD GROUP INC ($1.29B). Insider activity: Net Seller (0 buys, 20 sells). 6 recent congressional STOCK Act disclosures. SEC EDGAR first-party data.
| Holder | Shares | Market Value | Reported |
|---|---|---|---|
| VANGUARD GROUP INC | 16862691.00 | $1.29B | 2025-12-31 |
| BlackRock, Inc. | 14207757.00 | $1.06B | 2026-03-31 |
| Kohlberg Kravis Roberts & Co. L.P. | 13260971.00 | $984.76M | 2026-03-31 |
| JANUS HENDERSON GROUP PLC | 13179013.00 | $978.61M | 2026-03-31 |
| VIKING GLOBAL INVESTORS LP | 11842434.00 | $879.42M | 2026-03-31 |
| FARALLON CAPITAL MANAGEMENT LLC | 9365463.00 | $695.48M | 2026-03-31 |
| VANGUARD PORTFOLIO MANAGEMENT LLC | 8080573.00 | $600.06M | 2026-03-31 |
| VANGUARD CAPITAL MANAGEMENT LLC | 7759495.00 | $576.22M | 2026-03-31 |
| Insider | Transaction | Value | Date |
|---|---|---|---|
| Sell | null | 2026-06-15 | |
| Sell | null | 2026-06-15 | |
| Sell | null | 2026-06-15 | |
| Sell | null | 2026-06-15 | |
| Sell | null | 2026-06-15 | |
| Sell | null | 2026-06-15 | |
| Sell | null | 2026-06-04 | |
| Sell | null | 2026-06-04 |
Back to BBIO overview · BBIO earnings · All congressional trades
Institutional data from SEC Form 13F. Insider data from SEC Form 4. Congressional data from STOCK Act disclosures. Not personalized investment advice.